Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00248547 · ADVERSE EVENTS

Adverse events

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant · Source last updated 2017-05-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
Not reported
Other-event reporting threshold
5%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Aprepitant

Loading dose of 125 mg capsule once a day for one day, then maintenance dose of 80 mg capsule daily through Day +4 of Bone Marrow Transplant

2 / 200 / 20Not reported / Not reported
Placebo

Loading dose of 125 mg capsule once a day for one day, then maintenance dose of 80 mg capsule daily through Day +4 of Bone Marrow Transplant

0 / 200 / 20Not reported / Not reported

Group identifiers: EG000: Aprepitant · EG001: Placebo

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      20
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      20
    term
    Subileus

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Complete source fields
    event Groups
    1. description
      Loading dose of 125 mg capsule once a day for one day, then maintenance dose of 80 mg capsule daily through Day +4 of Bone Marrow Transplant
      id
      EG000
      other Num Affected
      0
      other Num At Risk
      20
      serious Num Affected
      2
      serious Num At Risk
      20
      title
      Aprepitant
    2. description
      Loading dose of 125 mg capsule once a day for one day, then maintenance dose of 80 mg capsule daily through Day +4 of Bone Marrow Transplant
      id
      EG001
      other Num Affected
      0
      other Num At Risk
      20
      serious Num Affected
      0
      serious Num At Risk
      20
      title
      Placebo
    frequency Threshold
    5
    serious Events
    1. organ System
      Gastrointestinal disorders
      stats
      1. group Id
        EG000
        num Affected
        2
        num At Risk
        20
      2. group Id
        EG001
        num Affected
        0
        num At Risk
        20
      term
      Subileus

    Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

    Preserved source evidence · Not medical advice